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Cardiometabolic Health Among Cancer Survivors:  
A 13-Week Pilot Study of a Combined Aerobic  
and Resistance Training Program
Silvie Grote, MS, MA, RCEP, Hawley C. Almstedt, PhD, RD,  
and Heather P. Tarleton, PhD, MS, MPAP
ARTICLE
E arly detection through cancer screening and the increased efficacy of cancer treatments have improved the chances of survival among pa-tients with cancer (Siegel et al., 2012). As of 2014, the estimated preva-lence of cancer survivors in the United States was 14.5 million, with about 64% being considered 5-year survivors and 15% being considered 
20-year survivors (DeSantis et al., 2014). Cancer survivors are living longer but 
with a greater comorbid burden than similarly aged individuals without cancer. 
Purpose/Objectives: To explore the feasibility of combined aerobic and resistance training 
(CART) as a safe method of improving cardiometabolic health among cancer survivors.
Design: Descriptive and longitudinal pilot study for exercise intervention.
Setting: University campus in Los Angeles, California.
Sample: A multiethnic population of cancer survivors (N = 11) was recruited by convenience 
sampling and physician referral. 
Methods: Consenting participants were prescribed CART for one hour per day, three days 
per week for 13 weeks.
Main Research Variables: Components of cardiometabolic health were measured, includ-
ing resting heart rate (HRrest), blood pressure, body mass index, waist circumference, body 
fat percentage, and android fat percentage at baseline and after 13 weeks of training. Fast-
ing blood glucose, insulin, adiponectin, leptin, tumor necrosis factor alpha, and C-reactive 
protein (CRP) also were assessed at baseline and after 13 weeks of training.
Findings: More than half of the participants reported living with at least two other chronic 
diseases or conditions in addition to a cancer diagnosis. Five of six African American and 
Hispanic participants reported the presence of at least two risk factors for metabolic 
syndrome, compared to one of five Caucasian participants. After 13 weeks of training, 
participants experienced an average decrease in waist circumference. Decrease in waist 
circumference was associated with a decrease in CRP. A relationship also was suggested 
between number of exercise sessions attended and improvement in HRrest. 
Conclusions: A CART intervention among cancer survivors should continue to be explored 
in a larger sample to establish efficacy and effectiveness at improving cardiometabolic 
health. Because of the higher risk of comorbidity among cancer survivors in comparison to 
cancer-free adults, improving cardiometabolic health is as important as monitoring cancer 
recurrence. A need exists for increased attention to the post-treatment cardiometabolic 
health of cancer survivors and also for examining potential cardiometabolic health dispari-
ties among non-Caucasian cancer survivors.
Implications for Nursing: CART may be a plausible alternative to reduce the risk of meta-
bolic syndrome and improve cardiometabolic health among cancer survivors. Additional 
studies that continue to explore the efficacy and effectiveness of CART may provide more 
information to help nurses and physicians determine whether the cancer survivorship care 
plan should include an exercise-based alternative to intervene on cardiometabolic health.
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Previous research indicates that cancer survivors 
experience a higher burden of chronic disease, dis-
ability, and obesity compared to cancer-free adults 
(Leach et al., 2015; Tarleton, Ryan-Ibarra, & Induni, 
2014). Additional studies specifically report that long-
term survivors were more likely to have risk factors 
for type 2 diabetes mellitus (T2DM) and cardiovascu-
lar disease (CVD) in comparison to their cancer-free 
counterparts (Daher, Daigle, Bhatia, & Durand, 2012; 
Underwood et al., 2012; Weaver et al., 2013).
T2DM and CVD are clinically defined by poor cardio-
metabolic health. Cardiometabolic health is influenced 
by level of adiposity and dependent on properly func-
tioning cardiovascular and metabolic systems (see 
Figure 1). Adiposity in the central region of the body, 
often referred to as the android region, is particularly 
associated with components of metabolic syndrome, 
dyslipidemia, hypertension, and insulin resistance 
(Antuna-Puente, Feve, Fellahi, & Bastard, 2008; Galic, 
Oakhill, & Steinberg, 2010; Rasouli & Kern, 2008). Insu-
lin resistance also is widely recognized as a late effect 
of chemotherapy and radiation therapy (Guinan et al., 
2014; Rajendran, Abu, Fadl, & Byrne, 2013; Vergès, Wal-
ter, & Cariou, 2014). Treatment-related cardiotoxicity 
and radiation-related damage to the cardiovascular 
and respiratory systems also exacerbate the risk for 
CVD (Ewer & Ewer, 2010; Fuchs et al., 2003).
Because metabolic syndrome strongly predisposes 
patients to T2DM and CVD, it is emerging as one of 
the greatest concerns of oncology practitioners. The 
majority of published studies of metabolic syndrome 
among cancer survivors largely have focused on 
breast cancer survivors and the prevalence of obe-
sity because of treatment-related effects on hormone 
status and ability to engage in physical activity. About 
40% of breast cancer survivors are overweight or 
obese and, among this population, the prevalence of 
metabolic syndrome ranges from 50%–55% (Buttros 
Dde et al., 2013; Elme et al., 2013; Ortiz-Mendoza, de-
la-Fuente-Vera, & Pérez-Chávez, 2014). Obesity and 
metabolic syndrome among survivors also can be 
accompanied by elevated levels of C-reactive protein 
(CRP), a pro-inflammatory risk factor for poor cardio-
vascular health (Buttros Dde et al., 2013). 
One nonpharmacologic way to improve cardiometa-
bolic health among cancer survivors is to prescribe 
aerobic exercise combined with resistance training. 
Moderate-intensity exercise supports health and 
improves quality of life among cancer survivors by 
reducing adiposity and biomarkers associated with 
T2DM and CVD (Anand et al., 2011; Lin et al., 2010; 
Lujan & DiCarlo, 2013). The combination of aerobic 
exercise and resistance training can promote healthy 
cardiovascular, endocrine, and musculoskeletal sys-
tems (Friedenreich, Neilson, & Lynch, 2010; Lee et al., 
2012). Aerobic exercise and resistance training also 
may have positive effects on resting heart rate (HRrest) 
and blood pressure (BP) and may improve the cardio-
respiratory health of post-treatment cancer survivors 
(Midtgaard et al., 2013; Schmitz et al., 2005). In ad-
dition, regular participation in an exercise program 
that includes resistance training may remediate late 
effects of treatment, such as fatigue and cardiotoxicity 
(Brown et al., 2011).
Previously published studies of training programs 
for cancer survivors vary in the exercise prescription 
and outcomes measured. Programs that prescribed 
moderate-intensity exercise consistently noted sig-
nificant improvements in body composition, biomark-
ers, or cardiovascular health (Allgayer, Nicolaus, & 
Schreiber, 2004; Guinan et al., 2013; Hayes, Davies, 
Parker, & Bashford, 2003; Hsieh et al., 2008), whereas 
programs based on walking or low-intensity exercise 
did not report measurable change in these risk fac-
tors. Although the benefits of moderate-intensity 
exercise have been shown to be greater than those of 
low-intensity programs, the length of the prescribed 
programs and which outcomes are assessed vary. The 
Cardiovascular Disease
• Increased resting heart rate 
• Elevated C-reactive protein
• Elevated triglycerides
• Elevated low-density lipoprotein
• Decreased high-density lipoprotein
• Increased blood pressure
Metabolic Syndrome
• Elevated triglycerides
• Elevated low-density lipoprotein
• Decreased high-density lipoprotein
• Increased blood pressure
• Increased fasting blood glucose
Type 2 Diabetes Mellitus
• Increased blood insulin
• Increased fasting blood glucose
FIGURE 1. Clinical Determinants of Cardiometabolic 
Health
Central Adiposity
• Increased waist circumference
• Increased android fat percentage
• Increased body fat percentage
• Increased leptin
• Decreased adiponectin
• Increased tumor necrosis factor–alpha
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majority of the previously published work focuses on 
weight loss or biomarkers (Allgayer et al., 2004) or on 
cardiovascular health (Broderick et al., 2013; Dimeo, 
Fetscher, Lange, Mertelsmann, & Keul, 1997; Hsieh et 
al., 2008) as independent outcomes. To the research-
ers’ knowledge, only one study has approached car-
diometabolic health comprehensively and assessed 
the prevalence of metabolic syndrome among cancer 
survivors (Guinan et al., 2013). 
The purpose of this pilot implementation of the 
improving physical activity after cancer treatment 
(IMPAACT) study is to evaluate whether 13 weeks 
of combined aerobic and resistance training (CART) 
could safely and feasibly improve cardiometabolic 
health and reduce comorbidities. This study also 
aims to assess the feasibility of analyzing all three of 
the cardiometabolic health domains (anthropometric, 
functional, and biomarker) and metabolic syndrome 
in the same study population as important outcomes 
for an exercise training intervention.
Methods
Design 
The IMPAACT study was approved by the Loyola 
Marymount University (LMU) Institutional Review 
Board and conducted on LMU’s Westchester campus 
in Los Angeles, California. A multiethnic population of 
cancer survivors responded to recruitment by con-
venience sampling methods, which included survey 
distribution and flyers within a 15-mile radius of LMU’s 
campus, physician referral, and local community elec-
tronic mailing lists. Of the 24 survivors who expressed 
interest, 11 provided written consent to participate in 
the feasibility study. Reasons reported by 13 survivors 
for declining participation included transportation limi-
tations, work schedules, lack of child care, and poor 
health. All cancer survivors who participated in the 
study provided written informed consent. Interested 
survivors were excluded if they were experiencing 
recurrent cancer or a new primary cancer, currently 
receiving radiation or chemotherapy, had a myocardial 
infarction or stroke within the past year, had lymph-
edema or inflammation of the pelvis or lower extremi-
ties, had a history of fainting while exercising, or had 
a history of chest pain or shortness of breath brought 
on by exercise. Participants were asked to inform 
their physicians of their planned participation and to 
review the exercise and assessment protocols with 
their physicians. Eleven participants were assessed at 
baseline by a registered clinical exercise physiologist 
to determine whether the exercise intervention was 
appropriate for their individual ability. Two partici-
pants withdrew from the study between baseline and 
postintervention assessments, citing increased family 
responsibilities. The remaining nine participants com-
pleted the 13-week intervention and the baseline and 
postintervention assessments.
Data Collection
Demographic characteristics, medical history, 
reproductive history, and physical activity patterns 
were obtained at baseline from a self-administered 
questionnaire. Cardiovascular health was assessed at 
baseline and postintervention by a registered clinical 
exercise physiologist as participants rested supine 
for 10 minutes in a quiet environment, free of sensory 
stimulation. HRrest and BP were recorded as the low-
est HR during and as the average of two consecutive 
measurements at the conclusion of the rest period, 
respectively. Height, waist circumference, and weight 
were measured by exercise physiologists using a sta-
diometer (cm), tape measure (cm), and digital scale 
(kg), respectively, at baseline and postintervention. 
Waist circumference measurements are established as 
a practical, valid, and reliable method to quantify fat 
in the abdominal region and predict risk for chronic 
disease (Klein et al., 2007). Specifically, waist circum-
ference was the perimeter measured at the narrowest 
circumference of the body between the lowest rib and 
the iliac crest. Participants wore minimal clothing, and 
measurements were taken after exhaling while arms 
hung freely. The tape measure, made of non-stretch 
material, was placed perpendicular to the long axis 
of the body with the tape snug, but not compressed, 
against skin. The Aerobic Center Longitudinal Study 
Physical Activity Questionnaire (Pereira et al., 1997) 
was used to assess regular physical activity for three 
months prior to study enrollment. This validated ques-
tionnaire is self-administered and allows for evaluation 
of intensity (in metabolic equivalents) and duration 
of regular physical activity (Kohl, Blair, Paffenbarger, 
Macera, & Kronenfeld, 1988).
Dual-energy x-ray absorptiometry (DXA) analysis 
of body composition was performed at baseline and 
postintervention. DXA of the whole body was used to 
quantify whole body fat percentage and fat percent-
age in the android body segment. The DXA analysis 
software defines the android region of interest as the 
approximate area around the waist between the mid-
point of the lumbar spine and the superior border of 
the pelvis.
Fifteen milliliters of an overnight fasting blood 
sample were collected from each consenting partici-
pant by a licensed phlebotomist using venipuncture 
at baseline and postintervention time points. Fasting 
blood glucose (FBG) and insulin were assessed as risk 
factors for T2DM (Rynders et al., 2014). Adiponectin 
and leptin are adipokines produced by adipose tissue 
and were assessed as risk factors for T2DM and CVD 
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(Diaz, Karlan, & Li, 2013). Tumor necrosis factor (TNF)–
alpha and CRP are biomarkers of inflammation and 
were assessed as risk factors for CVD (Folsom, 2013; 
van Holten et al., 2013). Blood samples were processed 
at the LMU Biomedical Science laboratory by trained 
laboratory technicians for serum separation, aliquot-
ed, and stored at –80°C. Levels of insulin (intra-assay 
3% coefficient of variation [CV], inter-assay 11% CV), 
adiponectin (intra-assay 4% CV, inter-assay 10% CV), 
leptin (intra-assay 5% CV, inter-assay 13% CV), TNF-
alpha (intra-assay 2.6% CV, inter-assay 13% CV), and 
CRP (intra-assay < 10% CV, inter-assay < 15% CV) were 
analyzed at the Norris Comprehensive Cancer Center 
at the University of Southern California in Los Angeles. 
FBG was assessed at the University of California, Los 
Angeles Clinical and Translational Research Laborato-
ry on an Olympus AU400® chemistry immuno-analyzer 
platform (intra-assay < 2% CV, inter-assay < 3% CV).
Thresholds for biomarker assessments were set 
according to expected values identified in the litera-
ture. Participants could be classified at baseline as 
prediabetic based on an FBG of more than 100 mg/
dl or a fasting blood insulin level of more than the 
recommended threshold of 20 mcU/ml, which is com-
parable to levels observed among individuals with 
T2DM and metabolic syndrome (García-Jiménez et al., 
2015). Observed leptin levels of more than 20 ng/ml 
are within a range associated with being overweight 
or obese and insulin resistance (Zuo et al., 2013). 
Adiponectin levels of less than 15 mcg/ml are associ-
ated with being overweight or obese, and CRP levels 
of more than the threshold of 3 mg/L and less than 
10 mg/L are considered to be at high risk for chronic 
inflammation (Ridker et al., 2008).
Cardiometabolic health was defined according to 
clinical criteria put forth by the National Heart, Lung, 
and Blood Institute at the National Institutes of Health 
(Nelms, Sucher, Lacey, & Roth, 2011). Based on these 
criteria, an individual with three or more of the fol-
lowing cardiometabolic risk factors can be clinically 
diagnosed with metabolic syndrome: a large waistline 
with increased risk, defined as greater than 88 cm for 
women and greater than 102 cm for men; triglyceride 
level of 150 mg/dl or greater; high-density lipoprotein 
cholesterol level of less than 50 mg/dl for women and 
less than 40 mg/dl for men; BP of 130/85 mmHg or 
greater; FBG of 100 mg/dl or greater; or currently taking 
medication for high cholesterol, high BP, or high FBG.
Exercise Intervention
The IMPAACT study is a supervised CART program 
prescribed for one hour per day, three days per week. 
Each exercise session includes: (a) 20 minutes of car-
diorespiratory training; (b) 25 minutes of circuit-style 
combined resistance and cardiorespiratory training; 
and (c) 15 minutes of core training, flexibility exercises, 
and cool down. All exercise is prescribed in accordance 
with the American College of Sports Medicine (ACSM) 
exercise guidelines for cancer survivors (Schmitz et 
al., 2010). Prescribed cardiovascular intensity is de-
termined using the Karvonen Formula (exercise target 
HR = [HR reserve] x percentage of exercise intensity + 
HRrest), in combination with medical history and cur-
rent level of activity and physical fitness. HR reserve 
(maximal HR [HRmax] – HRrest) is a function of measured 
HRrest and HRmax, the latter of which is predicted based 
on participant’s age (HRmax = 220 – age).
During the CART program, cardiorespiratory train-
ing included walking or using an elliptical machine or 
stationary bike to achieve an individually prescribed 
target HR training zone (40%–80% of HR reserve) by 
referring to an HR monitor. Circuit training included 
sets of eight upper and lower body exercises. During 
week 1, two sets of circuit training were performed for 
two minutes for program acclimation and correction 
of form, and then decreased to one minute during 
week 2. Beginning with week 3, the circuit training was 
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 High school 1
 Some college 2
 Two-year college graduate 2





 Hodgkin lymphoma 1
 Lung 1
Time since treatment
 Less than 1 year 4
 1–4 years 2
 5 years or more 5
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performed as three sets, with each set lasting 45 sec-
onds, followed by a brief 20-second rest period. Core 
training involved two to three exercises to improve 
abdominal and trunk strength, which were accom-
panied by dynamic and static stretching to increase 
range of motion.
The exercises involved in the resistance circuit 
included different modes of upper- and lower-body 
resistance training, whole-body vibration, and lateral 
walking. Varied resistance or intensity was provided 
with elastic resistance bands, increasing step heights 
(4, 6, 8 inches), or varied body positions and body 
weight for resistance. All participants were provided 
customized options at each station to account for 
functional or injury limitations. Whole-body vibration 
was included to promote potential improvements in 
muscular strength (Lau et al., 2011), bone density (Slat-
kovska, Alibhai, Beyene, & Cheung, 2010), and neurop-
athy (Kessler & Hong, 2013). Training was performed 
on a Vibraflex® 550 platform (also called the Galileo® 
2000). Vibration began at 30 seconds and 20 Hz for 
the first four weeks of the program and progressed 
to a 45-second duration at 25 Hz, with participants 
performing simple movements such as heel raises and 
partial squats concurrently during vibration exposure. 
Statistical Analysis
Changes in anthropometrics, functional variables, 
and biomarkers were evaluated before and after 13 
weeks of training. Simple relationships were assessed 
by Pearson’s correlation coefficients. All determina-
tions were performed using SPSS®, version 18.2. 
Results
Baseline Characteristics
The IMPAACT study volunteers were a multiethnic 
population, with more than half of the participants 
self-identifying as African American or Hispanic (see 
Table 1). Participants (N = 11) were largely female 
and breast cancer survivors without a history of 
metastatic disease, and the average cohort age was 
about 58 years. The majority of participants were less 
than five years since the time of their last treatment.
The ACSM recommends at least 150 minutes of 
moderate-intensity physical activity each week 
(Schmitz et al., 2010). Based on responses collected 
using the Aerobics Center Longitudinal Physical Ac-
tivity Questionnaire (Pereira et al., 1997), at baseline, 
6 of 11 participants self-reported that their regular 
physical activity met ACSM guidelines. No partici-
pants were performing vigorous activity before en-
rollment. At baseline, two participants presented 
with at least three cardiometabolic risk factors and 
could have been clinically diagnosed with metabolic 
syndrome (see Table 2). More than half of participants 
reported gaining weight in the year prior to joining 
the study, with the most frequently reported gain be-
ing 5–10 pounds.
In addition to being diagnosed with cancer, 10 par-
ticipants self-reported a clinical diagnosis of at least 
one other chronic disease or condition. Seven partici-
pants reported living with at least two other chronic 
diseases or conditions, in addition to being a cancer 
survivor. The most commonly reported chronic dis-
eases and conditions at baseline included high BP (n = 
2), thyroid conditions (n = 5), chronic bronchitis (n = 
2), and osteoporosis or osteopenia (n = 2). 
Cardiovascular Health and Body Composition 
Cardiovascular variables, such as HRrest and BP, are 
displayed in Table 3. Four of 11 participants met the 
American Heart Association criteria for diagnosis of 
prehypertension (Midtgaard et al., 2013). Body com-
position and anthropometric data are presented for 
all participants and by race/ethnicity. At baseline, 5 
of 11 participants were classified as overweight (body 
mass index [BMI] > 25 kg/m2) and another three were 
classified as obese (BMI > 30 kg/m2). When examining 
waist circumference at study entry, Caucasian women 
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displayed a smaller waistline than African American 
women. 
Metabolic Syndrome and Biomarkers  
of Cardiometabolic Health
Ten of 11 participants who completed the interven-
tion provided fasting blood specimens for biomarker 
analysis. One participant declined to provide a blood 
specimen, citing a preexisting difficulty with giving 
blood because of venous damage from chemotherapy. 
At baseline, 3 of 10 participants who volunteered blood 
specimens could be classified as prediabetic based on 
an FBG of more than 100 mg/dl (
—
X = 112 mg/dl [SD = 
12]), and one participant was at increased risk for 
prediabetes (FBG = 98 mg/dl). One participant had an 
elevated fasting blood insulin level of 22.9 mcU/ml, and 
one participant had a higher risk level of fasting blood 
insulin at 18.7 mcU/ml. Two participants had slightly 
increased leptin levels in the 15–20 ng/ml range, four 
participants had leptin levels of more than 20 ng/ml 
(
—
X = 35.4 ng/ml [SD = 17.1]), and five participants had 
adiponectin levels of less than 15 mcg/ml (
—
X = 11 mcg/
dl [SD = 3.18]). One participant had a high-risk CRP 
level of 4.66 mg/L, and one participant had 
an elevated CRP level of 2.72 mg/L.
After 13 weeks of training, improvements 
were observed in prevalence of metabolic 
syndrome and in biomarkers of cardiometa-
bolic health (see Tables 4 and 5). Decreases 
in waist circumference were associated with 
a decrease in CRP (r2 = 0.692). The largest 
decreases in CRP were observed among 
those with the greatest android fat mass at 
baseline (r2 = 0.826). Number of sessions 
attended was positively correlated with de-
creases in insulin (r2 = 0.72) and decreases in 
leptin (r2 = 0.785). Time since last treatment 
was positively correlated with decreases in 
insulin levels (r2 = 0.8) and FBG (r2 = 0.757). 
The researchers’ analysis also suggested 
that participants with the longest time since 
last treatment experienced the greatest de-
crease in interleukin-10 levels after training 
(r2 = 0.647). No relationships were observed 
between participation with adiponectin or 
TNF-alpha after 13 weeks of CART. 
Postintervention Change  
in Cardiometabolic Health
Adherence to the prescribed exercise 
intervention (one hour per day, three days 
per week for 13 weeks, with 38 possible 
sessions) ranged from 24%–97%, with an 
average participation of 63% (SD = 27%). Rea-
sons reported for missing sessions included 
changes in work schedules, childcare responsibilities, 
temporary illness (e.g., seasonal colds), and family 
vacations. Six of the 11 participants experienced a 
weight gain of 5–15 pounds in the year prior to study 
enrollment. Postintervention analysis showed an av-
erage decrease in waist circumference of 1.8 cm (SD 
= 3.97), with three of nine participants experiencing 
more than a 3 cm reduction in waist circumference. 
The participants with the largest decrease in waist 
circumference were also participants who attended 
more than 70% of the training sessions during the 13-
week pilot study. As a whole, participants experienced 
an 11% decrease in average fat mass of the android 
body region. A trend of a decrease in android total 
mass, android fat percentage, and whole body fat 
percentage was seen. No significant change was ob-
served from baseline to postintervention of HRrest or 
BP. However, a relationship was found between num-
ber of sessions attended and improvement in HRrest.
No injuries were reported during the CART ex-
ercise sessions, and, during the 13-week IMPAACT 
program, no harm was reported by participants from 
the prescribed exercise.
TABLE 3. Cardiovascular Health and Body Composition
Baseline  
(N = 11)








 Total 64.6 13.1 67.1 13
 African Americans/Hispanics 66.5 16.3 73.4 11
 Caucasians 62.4 9.2 59.3 11.9
Systolic BP (mmHg)
 Total 115.4 12.9 118.4 11.3
 African Americans/Hispanics 118 12.3 125.5 4.6
 Caucasians 112.2 14.2 109.6 11.1
Diastolic BP (mmHg)
 Total 70.6 7 71.8 9.8
 African Americans/Hispanics 72.5 5.1 75.7 10.8
 Caucasians 68.4 8.9 66.9 6.5
Body mass index (kg/m2)
 Total 26.9 3.5 26.6 3.7
 African Americans/Hispanics 28.8 3 29.1 3
 Caucasians 24.6 2.8 23.5 1.4
Waist circumference (cm)
 Total 86.7 10.4 84.9 8.8
 African Americans/Hispanics 89.9 6.1 89 9
 Caucasians 83.1 13.9 79.6 5.9
Whole body fat (%)
 Total 38.4 5.6 38 6.2
 African Americans/Hispanics 41.3 5.2 40.7 6.9
 Caucasians 35.5 4.9 35.3 4.8
Android fat (%)
 Total 37.6 7.1 36.1 8.5
 African Americans/Hispanics 40.1 3 40 6.6
 Caucasians 35 9.4 31.2 7.9
BP—blood pressure; BPM—beats per minute; HRrest—resting heart rate
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Discussion
The IMPAACT study explored the preliminary effi-
cacy of an exercise prescription for CART by assessing 
three domains of change in cardiometabolic health: 
anthropometric, functional, and biomarker. Through 
cross-sectional assessment in the small sample of mul-
tiethnic cancer survivors who had completed cancer 
treatment, the researchers found that 10 participants 
self-reported comorbid conditions of chronic disease. 
In addition, two participants were found to exhibit 
three or more risk factors of cardiometabolic health 
and could be diagnosed with metabolic syndrome.
The researchers explored the feasibility of whether 
a relatively short 13-week aerobic and resistance 
training intervention could influence cardiometabolic 
health and observed patterns of improvement in the 
anthropometric, functional, and biomarker-related 
risk factors for metabolic health within the study pop-
ulation. Improvements in waist circumference, body 
composition, and HRrest suggest that CART could be a 
safe and effective method of improving cardiometa-
bolic health for cancer survivors. The relationships 
observed in this feasibility study between exercise 
participation and changes in biomarkers of cardio-
metabolic health suggest that repeating this interven-
tion with a larger sample size and longer intervention 
would be worthwhile. With at least six months of 
training, visualizing temporal relationships between 
anthropometric and functional changes and improve-
ments in cardiometabolic biomarkers may be possible 
(Ryan, Nicklas, Berman, & Elahi, 2003). Expanding this 
approach in a larger sample size also may allow for 
the analysis of demographic characteristics as media-
tors of potential temporal relationships.
Because of the racial homogeneity of previously 
published studies and the observed racial disparities 
in the baseline prevalence of metabolic syndrome in 
the current study population, a need exists for addi-
tional assessment of cardiometabolic health among 
non-Caucasian cancer survivors. Differences in risk 
and prevalence of T2DM, 
hypertension, and CVD 
have been observed in lon-
gitudinal and cross-section-
al comparisons of people 
who are African American 
and Caucasian (Brancati, 
Kao, Folsom, Watson, & Szk-
lo, 2000; Loehr et al., 2004). 
Disparities in comorbid 
burden have been reported 
among cancer survivors 
by race/ethnicity (Allard 
& Maxwell, 2009; Ashing, 
Rosales, Lai, & Hurria, 2014; Haynes & Smedley, 1999; 
Tammemagi, 2007; Winnick, Gaillard, & Schuster, 
2008). Previous research established that T2DM was 
more prevalent among Hispanic cancer survivors, 
and CVD and circulatory complications were more 
prevalent among African American cancer survivors 
(Schultz, Stava, Beck, & Vassilopoulou-Sellin, 2004).
The IMPAACT study was able to assess cardio-
metabolic health in a multiethnic cohort of cancer 
survivors and identify potential racial disparities 
in prevalence of metabolic syndrome and in levels 
of biomarkers of cardiometabolic risk. In general, 
Caucasian female participants showed a trend for im-
provement in variables of cardiovascular health and 
body composition, which was not observed in African 
American female participants. However, because the 
researchers did not observe statistically significant 
disparities in this feasibility study, repeating the in-
vestigation in a larger multiethnic population will be 
important to quantify these potential relationships 
between race and cardiometabolic outcomes.
The IMPAACT study design represents a unique shift 
toward assessing the effect of training on cardiometa-
bolic health, as represented by a profile that includes 
risk of metabolic syndrome, as well as abnormal levels 
of related biomarkers. In addition, the study also is 
innovative in using DXA-derived data in combination 
with anthropometric measures to objectively mea-
sure android fat mass, which is particularly relevant 
to T2DM and CVD. Although individual risk factors 
(e.g., BMI) are important to assess, the tendency to 
assess each risk factor independent of one another 
as risk factors for either T2DM or CVD may focus too 
narrowly on long-term outcomes. This may lead to a 
missed opportunity to intervene on cardiometabolic 
health in the early stages of metabolic syndrome, 
which would be of great benefit to this population 
of cancer survivors who already are experiencing 
greater morbidity in comparison to cancer-free adults.
Collectively, the researchers’ findings suggest that 
changes in markers of cardiometabolic health may be 
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associated with improvements in body composition 
and cardiovascular health. These positive benefits 
appear to be most salient for those who recently have 
completed treatment. The findings of this feasibility 
study may be of particular interest to nursing profes-
sionals who work with patients at the conclusion of 
cancer treatment. Although walking is an important 
activity for maintaining fitness, additional emphasis 
is needed by healthcare providers on quantifying the 
benefits of combined programs of aerobic exercise 
and resistance training on metabolic risk factors and 
remediating late treatment effects. CART also may 
reduce the long-term risk for chronic disease after 
cancer treatment. Continuing to explore potential 
relationships between biomarkers, body composition, 
and cardiovascular health in response to exercise in 
larger, multiethnic populations of cancer survivors 
is important. 
Limitations
The current study is limited by sample size, but 
it remains comparable to samples sizes reported in 
seven feasibility studies of cancer survivors (Bal-
neaves et al., 2014; Campbell et al., 2012; Cormie 
et al., 2013; Frensham, Zarnowiecki, Parfitt, King, & 
Dollman, 2014; Katz et al., 2010; Peddle-McIntyre, 
Bell, Fenton, McCargar, & Courneya, 2012; Spector, 
Deal, Amos, Yang, & Battaglini, 2014). These stud-
ies also are comparable 
in the focus on piloting 
in-person or group-based 
exercise interventions 
with the goal of address-
ing treatment-related ef-
fects and comorbidity. 
The lack of comparison 
to a control group in the 
current study limits the 
abil ity to understand 
changes in cardiometa-
bolic health after cancer 
treatment without exer-
cise. However, because 
of the longitudinal design, 
each participant serves 
as his or her own control, 
with the baseline assess-
ment of each participant 
providing a reference for 
cardiometabolic health. 
The short duration of 
the exercise intervention 
limits interpretation, but 
small positive improve-
ments suggest that CART 
of longer duration may be beneficial to the cardio-
metabolic health of cancer survivors. 
Conclusion and Implications  
for Nursing
Cancer survivorship is a distinct stage of the cancer 
experience and is highly dependent on sustainable 
health promotion after treatment. A comprehensive 
cancer survivorship plan can aid cancer survivors in 
enhancing the transition from treatment to the next 
life stage and improving treatment outcomes. Nurses 
have an opportunity to build relationships with can-
cer survivors because they see the same patients 
during different stages of treatment and follow-up. The 
role of oncology nurses in patient education in the 
areas of nutrition and lifestyle interventions has been 
established by the review of international research 
evidence, clinical literature, and analysis of current 
policy. A need exists for enhancement of professional 
guidance in nursing with regard to physical activity 
so that nurses know what to safely recommend to 
effectively promote good cardiometabolic health and 
to know when these recommendations may be most 
pertinent.
Because of prior findings and those of the current 
study, oncology nurses are well positioned to deliver 
guidance regarding physical activity and engagement 
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Adiponectin (mcg/ml) 18.31 9.05 21.51 11.27 15.1 5.62
Blood insulin (mcU/ml) 12.49 6.66 11.37 7.12 13.61 6.79
C-reactive protein (mg/L) 3.17 2.88 3.59 3.37 1.89 –
Fasting blood glucose (mg/dl) 94.1 15.17 91 20.31 97.2 9.03
Leptin (ng/ml) 23.51 16.09 15.06 5.89 31.97 19.22
TNF-alpha (pg/ml) 10.7 2.23 10.87 2.73 10.53 1.9
13 weeks
Adiponectin (mcg/ml) 20.25 5.81 22.1 6.42 18.41 5.34
Blood insulin (mcU/ml) 8.61 4.56 5.68 1.73 11.53 4.77
C-reactive protein (mg/L) 2.35 1.19 2.36 1.46 2.33 –
Fasting blood glucose (mg/dl) 93.25 10.74 87.5 5.56 99 12.24
Leptin (ng/ml) 23.01 16.21 12.97 3.94 33.06 18.13
TNF-alpha (pg/ml) 9.05 2.94 7.67 3.36 10.88 0.44
TNF—tumor necrosis factor
Note. At baseline, of 11 total participants, 5 were Caucasian and 6 were African American 
or Hispanic. After 13 weeks, of 8 total participants, 4 were Caucasian and 4 were African 
American or Hispanic.
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in regular exercise as a means of mediating T2DM and 
CVD risk factors at the point of a patient’s transition 
from cancer treatment to post-treatment survivorship. 
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